PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME
Clinical trials for PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME trials appear
Sign up with your email to follow new studies for PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune therapy tested for Kids' Sudden-Onset OCD
Disease control CompletedThis Phase 3 trial tested whether an immune therapy called Panzyga (IVIG) could reduce severe obsessive-compulsive and behavioral symptoms in children with Pediatric Acute-onset Neuropsychiatric Syndrome (PANS/PANDAS). The study involved 71 children and teenagers, comparing Panzy…
Matched conditions: PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME
Phase: PHASE3 • Sponsor: Octapharma • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Families reveal hidden costs of rare childhood brain disorder treatment
Knowledge-focused CompletedThis study surveyed families about the financial and quality of life impacts of IVIG treatment for PANS/PANDAS, rare neuropsychiatric conditions in children. Researchers collected information from 65 U.S. participants who either received IVIG treatment or considered it. The goal …
Matched conditions: PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME
Sponsor: Brain Inflammation Collaborative • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC